Wound healing improvement by a multicomponent wound dressing of keratinocyte-imprinted polydimethylsiloxane substrate in a rabbit model

在兔模型中,角质形成细胞印迹聚二甲基硅氧烷基质的多组分伤口敷料可改善伤口愈合。

阅读:12
作者:Shima Alipour # ,Davoud Shams # ,Saeed Samani ,Soheila Pourkhodadad ,Setayesh Yasami-Khiabani ,Sana Banaeianzadeh ,Mohammad Mehdi Dehghan ,Seyed Mehdi Ghamsari ,Morteza Mehrjoo ,Fatemeh Alebrahim ,Shahram Azari ,Mohammad Ali Shokrgozar ,Shahin Bonakdar

Abstract

Wound healing is a major clinical challenge and regenerative medicine and tissue engineering suggest new ways to overcome such problems. The cell imprinting method can provide cues that regulate cell function or modulate stem cell differentiation into different lineages. In this study, the rabbit keratinocyte-imprinted polydimethylsiloxane (PDMS) substrate (KiPDMS) was made and associated with adipose-derived stem cells (ADSCs), keratinocytes, and collagen scaffold, provided various treatments. After evaluating ADSCs' differentiation into keratinocytes by qPCR and immunocytochemistry techniques, different treatments were implanted in a rabbit ear, histopathological analysis was performed on measuring the epidermal thickness and neovascularization. The histopathological analysis revealed that treated groups increased epidermal thickness (~ 139% up to ~ 998%) and neovascularization (vessel count /mm2, ~ 111% to ~ 301%) compared to the control group. Collagen scaffolds stimulated re-epithelialization, and implanting ADSCs with or without other factors enhanced its effect. Adding KiPDMS significantly improved re-epithelialization and neovascularization, especially in combination with differentiated keratinocytes. The complete treatment, consisting of all cellular and non-cellular stimulating factors, associated with a significant improvements in re-epithelialization and neovascularization compared with other treatments, including collagen scaffold and some other factors alone or together. These findings suggest that each treatment may have potential applications depending on the medical conditions, particularly in situations where cellular factors are limited.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。